Reduce your patients’ need to travel for treatment
We understand the critically important role that Direct-to-Patient logistics services (DtP) play in maintaining treatment schedules. By reducing the need to travel for treatment, we make it easier for researchers to recruit and retain qualified patients for their studies, and for manufacturers to broaden the patient populations who can benefit from their innovations.
We also know about the complexity and collaboration required to deliver this service. Our extensive global network gives us the ability to navigate local regulations and restrictions, allowing us to flawlessly transition your trials to a DtP model during COVID-19.
As the industry's partner of choice to enable at home clinical trials and specialty medicine delivery programs, our reach covers:
COVID-19 Resource Center
Stay updated on how we are supporting you through the pandemic
E-book: Developing Patient-Centric Partnerships for the 21st Century
Video: How to Implement Direct-to-Patient logistics
Improving patient experiences
Delivering precision and professionalism
Medical Research Network (MRN)
Partnering for better clinical trials
Article: How Are Our Customers Reacting to the Ongoing Impact of COVID-19?
Whitepaper: Decentralized Clinical Trials and Data Protection
Whitepaper: Maintaining Business Continuity